OncoHost
A Holistic Approach to Personalizing Cancer Treatment
Dr. Ofer Sharon, MD and CEO
Precision Oncology Solution
A Precision Oncology Solution delivers personalized cancer care through genomic profiling, biomarker analysis, and data-driven treatment planning. By integrating molecular diagnostics, AI, and targeted therapy insights, these platforms help clinicians identify optimal interventions, improve treatment accuracy, accelerate clinical decisions, and support better patient outcomes across oncology research and healthcare environments.
Solutions
OncoHost is leading a new era of personalized cancer care, where the patient’s biology, not just the tumor, guides the path forward.
State of Industry
Unlocking Therapeutic Precision through Integrated Omics
Precision oncology has evolved from targeting single genetic mutations to a comprehensive approach that harnesses the complete molecular profile of a tumor to guide personalized cancer treatment. This evolution, from discrete biomarkers to integrated multi-omics, signifies a pivotal shift, offering unprecedented opportunities for personalized treatment strategies. Early research unveiled specific gene mutations, amplifications, or fusions that acted as "driver" mutations, directly contributing to tumor growth and survival. These discoveries paved the way for the development of targeted therapies designed to inhibit the activity of these altered proteins specifically.
Deep Dive
Choosing Precision Oncology That Can Guide Treatment Decisions
Cancer care has reached a stage where diagnosis alone no longer provides enough information for clinicians to justify therapy selection, pathway design or investment in advanced decision-support systems. Oncology teams already rely on genomic testing, PD-L1 expression analysis, imaging and clinical judgment, yet many patients still receive therapies that deliver limited benefit, create unnecessary toxicity or delay more appropriate treatment options. For executives evaluating precision oncology platforms, the question is no longer whether additional data has value. The more important issue is whether a solution can translate complex biological information into timely guidance that meaningfully influences decisions at the point of care.
Leadership Perspective
the Janssen Pharmaceutical Companies of Johnson & Johnson
The Cancer Immunotherapy Treatment Paradigm
Charles G. Drake, M.D., Ph.D., Vice President, Immuno-Oncology
Please comment on your current role and responsibility in leading the cancer immunotherapy research and development at Janssen?
I lead the immuno-oncology team at Janssen where our efforts are focused on the discovery and development of next-generation approaches to immunotherapy that include antibody-based drugs, cell therapies, and novel cancer vaccines.
Precision Oncology Solution Info
Q1
What Do Precision Oncology Solution Providers Help Healthcare Organizations Achieve?
Top Precision Oncology Solutions help healthcare organizations, cancer centers and biotechnology companies develop more personalized cancer treatment strategies based on a patient’s genetic and molecular profile. These solutions support biomarker analysis, genomic sequencing, molecular diagnostics and targeted therapy selection. Many precision oncology providers also help clinicians identify treatment pathways that may improve therapeutic effectiveness while reducing unnecessary exposure to ineffective therapies. Precision oncology technologies are increasingly used to support individualized cancer care across research and clinical environments.
Q2
What Services and Technologies Are Included in Precision Oncology Solutions?
Top Precision Oncology Solutions commonly include genomic testing, biomarker profiling, companion diagnostics, data analytics and targeted therapy support. Some precision oncology technology providers also offer artificial intelligence tools, molecular tumor profiling and clinical decision-support systems. Precision oncology services may integrate laboratory diagnostics, patient data analysis and treatment-matching technologies to help clinicians make informed therapeutic decisions. Many healthcare organizations use these platforms to improve treatment personalization, clinical trial matching and disease monitoring across oncology programs.
Q3
Why Is Demand Growing for Precision Oncology Solutions?
Demand for Top Precision Oncology Solutions continues to rise because healthcare providers are increasingly adopting personalized cancer treatment approaches. Advances in genomic sequencing, biomarker research and targeted therapies have accelerated the use of precision medicine across oncology care. According to industry market research, the global precision oncology market was valued at more than USD 115 billion in 2024 and is projected to grow significantly over the next decade as adoption expands across healthcare systems and research organizations.
Q4
How Do Healthcare Organizations Evaluate Precision Oncology Solutions?
Organizations evaluating Top Precision Oncology Solutions often compare diagnostic accuracy, data integration capabilities and clinical applicability. Buyers may also assess regulatory compliance, interoperability with healthcare systems and the ability to support real-time clinical decision-making. Precision oncology platform providers are frequently reviewed based on genomic analysis capabilities, reporting quality and support for biomarker-driven therapies. Hospitals and cancer research organizations may additionally prioritize scalability, cybersecurity protections and evidence supporting treatment effectiveness and patient outcomes.
Q5
What Value Do Precision Oncology Solutions Deliver to Patients and Healthcare Systems?
Top Precision Oncology Solutions can help healthcare organizations improve treatment precision, reduce unnecessary therapies and support more informed cancer care decisions. Personalized treatment strategies based on molecular profiling may improve patient response rates while limiting exposure to therapies that are less likely to be effective. Precision oncology services also support earlier identification of targeted treatment opportunities and clinical trial eligibility. For healthcare systems, these technologies may contribute to improved care coordination, more efficient resource utilization and stronger long-term patient management outcomes.
Q6
How Are Innovation and Emerging Technologies Influencing Precision Oncology Solutions?
Innovation is reshaping Top Precision Oncology Solutions through artificial intelligence, multi-omics analysis and advanced molecular diagnostics. Many precision oncology technology companies are investing in machine learning models, longitudinal patient data analysis and spatial biology technologies to improve cancer treatment personalization. Emerging developments in biomarker discovery, liquid biopsy testing and data-driven clinical decision support are expanding how clinicians diagnose and manage cancer. Expertise in genomics, computational biology and targeted therapeutics continues to play an important role in advancing precision oncology innovation.
